| 1 | [SID103375475] | Active | Ki | 0.0004 | Binding affinity against Muscarinic acetylcholine receptors using [3H]oxotremorine-M as radioligand in rat cortex [AID142221, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103375475 | | CID | 60868 | | Outcome | Active | | Ki | 0.0004 [uM] | | BioAssay | Binding affinity against Muscarinic acetylcholine receptors using [3H]oxotremorine-M as radioligand in rat cortex | | AID | 142221 | | BioAssay type | Literature | | Target | | | PubMed | 9046345 | | Data Table |  |
|
| 2 | [SID103375475] | Active | IC50 | 0.0022 | In vitro inhibition of [3H]Oxo-Mas binding to M1 and M4 receptors in rat brain homogenate. [AID142501, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103375475 | | CID | 60868 | | Outcome | Active | | IC50 | 0.0022 [uM] | | BioAssay | In vitro inhibition of [3H]Oxo-Mas binding to M1 and M4 receptors in rat brain homogenate. | | AID | 142501 | | BioAssay type | Literature | | Target | | | PubMed | 9784113 | | Data Table |  |
|
| 3 | [SID85214108] | Active | | | Ligands of bioamine (Class A) GPCRs [AID2062, Type: other] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85214108 | | CID | 60868 | | Outcome | Active | | BioAssay | Ligands of bioamine (Class A) GPCRs | | AID | 2062 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID103375475] | Unspecified | | | Analgesic activity measured using mouse writhing antinociceptive assay after subcutaneous administration [AID128478, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103375475 | | CID | 60868 | | Outcome | Unspecified | | BioAssay | Analgesic activity measured using mouse writhing antinociceptive assay after subcutaneous administration | | AID | 128478 | | BioAssay type | Literature | | Target | | | PubMed | 9046345 | | Data Table |  |
|
| 5 | [SID103375475] | Unspecified | | | Conditioned avoidance responding in rat after subcutaneous administration (3 mg/kg); expressed as avoidance response/response failure [AID169193, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103375475 | | CID | 60868 | | Outcome | Unspecified | | BioAssay | Conditioned avoidance responding in rat after subcutaneous administration (3 mg/kg); expressed as avoidance response/response failure | | AID | 169193 | | BioAssay type | Literature | | Target | | | PubMed | 9784113 | | Data Table |  |
|
| 6 | [SID103375475] | Unspecified | | | Inhibition of conditioned avoidance response in rat following s.c. administration. [AID178179, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103375475 | | CID | 60868 | | Outcome | Unspecified | | BioAssay | Inhibition of conditioned avoidance response in rat following s.c. administration. | | AID | 178179 | | BioAssay type | Literature | | Target | | | PubMed | 9784113 | | Data Table |  |
|
| 7 | [SID103375475] | Unspecified | | | Intravenous effective dose required to produce a 1 mV increase in transmural potential difference in ferrets (GI side effect) [AID71930, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103375475 | | CID | 60868 | | Outcome | Unspecified | | BioAssay | Intravenous effective dose required to produce a 1 mV increase in transmural potential difference in ferrets (GI side effect) | | AID | 71930 | | BioAssay type | Literature | | Target | | | PubMed | 9046345 | | Data Table |  |
|
| 8 | [SID103375475] | Unspecified | | | Minimum intravenous effective dose required to inhibit jejunal motility in ferrets [AID71922, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103375475 | | CID | 60868 | | Outcome | Unspecified | | BioAssay | Minimum intravenous effective dose required to inhibit jejunal motility in ferrets | | AID | 71922 | | BioAssay type | Literature | | Target | | | PubMed | 9046345 | | Data Table |  |
|